Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newman, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newman, G. C.
NEUROLOGY 1985;35:1189
© 1985 American Academy of Neurology

Treatment of progressive supranuclear palsy with tricyclic antidepressants

George C. Newman, MD—PhD

Neurology Service, Veterans Administration Medical Center, North-port, NY: and the Departments of Neurology and Neurobiology and Behavior, State University of New York at Stony Brook, NY.

After a single patient with progressive supranuclear palsy (PSP) improved when given amitriptyline, we compared the effects of amitriptyline, desipramine, and placebo on the symptoms and signs of four patients with PSP in a double-blind, double-crossover manner. There was good correlation between the use of tricyclic agents and symptomatic improvement, although all patients remained disabled. Amitriptyline produced better overall improvement, whereas desipramine preferentially improved apraxia of eyelid opening.

Address correspondence and reprint requests to Dr. Newman, Department of Neurology, HSC T12-020, SUNY at Stony Brook, Stony Brook, NY 11794.

Accepted for publication December 5, 1984.




This article has been cited by other articles:


Home page
Arch NeurolHome page
K. Kompoliti, C. G. Goetz, I. Litvan, K. Jellinger, and M. Verny
Pharmacological Therapy in Progressive Supranuclear Palsy
Arch Neurol, August 1, 1998; 55(8): 1099 - 1102.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. Ghika and J. Bogousslavsky
Presymptomatic Hypertension Is a Major Feature in the Diagnosis of Progressive Supranuclear Palsy
Arch Neurol, September 1, 1997; 54(9): 1104 - 1108.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by AAN Enterprises, Inc.